Table 3.
Nonlinear mixed modeling: peak or nadir of inflammatory markers during the first 30 days post-AuSCT
Inflammatory marker | Estimated peak or nadir (days from transplant) | 95% CI | P |
---|---|---|---|
Markers with significant peak | |||
IL-6 | 9.00 | 6.01 to 11.99 | < 0.0001 |
CRP | 13.46 | 9.28 to 17.64 | < 0.0001 |
IL-10 | 18.01 | 13.43 to 22.59 | < 0.0001 |
Markers with significant nadir | |||
SIL-1RA | 4.71 | 1.69 to 7.72 | 0.003 |
SIL-6R | 8.16 | 5.40 to 10.93 | < 0.0001 |
Markers with no significant peak or nadir | |||
IL-8 | 0 | −47.1 to 47.1 | 0.999 |
STNF-R1 | 1.01 | −9.27 to 11.29 | 0.844 |
STNF-R2 | 2.40 | −2.56 to 7.37 | 0.335 |
MCP-1 | 2.74 | −0.04 to 5.52 | 0.054 |
TNF-α | 3.00 | −1.54 to 7.54 | 0.191 |
MIP-1α | 6.00 | 0.54 to 11.46 | 0.032 |
SIL-1R2 | 6.04 | −4.55 to 16.62 | 0.257 |
SIL-2RA | 18.00 | −38.31 to 74.31 | 0.524 |
Abbreviations: AuSCT, autologous hematopoietic stem cell transplant; CI, confidence interval.